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ABSTRACT
Objectives: Adiposity in middle age is an established
risk factor for cardiovascular disease and type 2
diabetes; less is known about the impact of adiposity
from early adult life. We examined the effects of high
body mass index (BMI) in early and middle adulthood
on myocardial infarction (MI), stroke and diabetes
risks.
Design: A prospective cohort study.
Participants: 7735 men with BMI measured in middle
age (40–59 years) and BMI ascertained at 21 years
from military records or participant recall.
Primary and secondary outcome measures:
30-year follow-up data for type 2 diabetes, MI and
stroke incidence; Cox proportional hazards models
were used to examine the effect of BMI at both ages
on these outcomes, adjusted for age and smoking
status.
Results: Among 4846 (63%) men (with complete
data), a 1 kg/m2 higher BMI at 21 years was associated
with a 6% (95% CI 4% to 9%) higher type 2 diabetes
risk, compared with a 21% (95% CI 18% to 24%)
higher diabetes risk for a 1 kg/m2 higher BMI in middle
age (hazard ratio (HR) 1.21, 95% CI 1.18 to 1.24).
Higher BMI in middle age was associated with a 6%
(95% CI 4% to 8%) increase in MI and a 4% (95% CI
1% to 7%) increase in stroke; BMI at 21 years showed
no associations with MI or stroke risk.
Conclusions: Higher BMI at 21 years of age is
associated with later diabetes incidence but not MI or
stroke, while higher BMI in middle age is strongly
associated with all outcomes. Early obesity prevention
may reduce later type 2 diabetes risk, more than MI
and stroke.
INTRODUCTION
Increased adiposity in middle age and later
life is an important risk factor for type 2
diabetes and cardiovascular disease,
especially coronary heart disease (CHD).1–5
There has been a worldwide increase in the
prevalences of overweight and obesity in
recent decades, particularly in higher
income countries.6–8 However, overweight
and obesity are increasingly affecting
younger as well as older people.7 Since high
levels of adiposity track strongly from child-
hood and early adulthood to middle age,
most people who become overweight in early
adult life will be overweight or obese in
middle age.9 10 There is growing concern
about the long-term health consequences of
increased exposure to adiposity from early
adult life, which may exacerbate the risks of
cardiovascular disease and type 2 diabetes in
later life.11 12
To understand the consequences of adipos-
ity over the life course requires studies with
Strengths and limitations of this study
▪ This investigation is based on a geographically
and socially representative cohort study with
high response rates and exceptionally high
follow-up rates.
▪ Linkage of military record data to this established
middle-aged cohort provides novel information
on early life exposures.
▪ The limited number of study participants with
high levels of body mass index (BMI) in early life
will have limited the power of the study for
detection of the effects of BMI in early adult life
on risks of myocardial infarction and stroke,
though they were detectable for diabetes.
▪ Effects of high early BMI on diabetes may be
potentially reversible by subsequent weight loss.
▪ Findings have important implications for type 2
diabetes prevention.
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accurate data on adiposity at several points of the life
course, including early adult life, middle age and in
later life, with extended follow-up for relevant out-
comes.12 13 Birth cohort studies often have information
on adiposity both before and during middle age,14–16
but generally have populations which are too young to
have large numbers of chronic disease events in later
life. Many prospective studies have data on adiposity in
middle age and its relation to subsequent chronic
disease outcomes,2 but few of these also have informa-
tion on adiposity in early adult life.12
We have therefore used a novel approach to provide
new information on this issue, obtaining data on mea-
sured weight and height in early adult life (at age
21 years) from military service records for participants in
an established cohort of almost 8000 men in whom body
mass index (BMI) has been studied in detail from
middle age (40–59 years) onwards, and for whom at
least 30 years of follow-up data on cardiovascular out-
comes and diabetes are available. For the purpose of
this report, BMI in early adult life (mean age 21 years)
and middle age (mean age 50 years) will be referred to
as BMI-21 and BMI-50.
METHODS
The British Regional Heart Study
The British Regional Heart Study (BRHS) is a prospect-
ive study of cardiovascular disease, and type 2 diabetes
among middle-aged and older British men. It is based
on 7735 men born between 1919 and 1939 who were
recruited in 1978–1980 aged 40–59 years from a single
general practice in 24 British towns (78% response
rate),17 and were followed up until the present. Study
men completed a detailed questionnaire on entry to the
study (including information on pre-existing cardiovas-
cular disease, type 2 diabetes and other medical condi-
tions, smoking status, physical activity, alcohol intake and
social class) and had measurements of weight and
height, measured with participants in light clothing
without shoes. Weight was measured to the last 0.1 kg
using regularly calibrated scales and height to the last
complete 0.1 cm using a Harpenden stadiometer.
Participants then completed periodic postal question-
naires about their health in 1983–1985, 1992 and 1996;
in 1996, they were asked to recall their weight at age
21 years. Men have been followed up over a 30-year
period for mortality, morbidity and disability with <2%
loss to follow-up.
Follow-up
Study participants were followed prospectively from the
baseline examination at 40–59 years for all-cause mortal-
ity, cardiovascular morbidity and diabetes incidence
from baseline to June 2010. Those with a doctor diagno-
sis of myocardial infarction (MI; n=134), stroke (n=19)
and diabetes (n=50) at baseline (n=195 in all) were
excluded. Follow-up has been achieved for 98% of the
cohort.17 Information on deaths was collected through
National Health Service Central Registers; death certiﬁ-
cates were coded using the International Classiﬁcation
of Diseases, Ninth Revision (ICD-9). Fatal MI was
deﬁned as ICD-9 codes 410–414 and fatal stroke as
ICD-9 codes 430–438. Information on non-fatal MI and
stroke events was obtained according to ongoing general
practitioner reports and two-yearly medical record
reviews.17 A non-fatal MI was diagnosed according to
WHO criteria.18 Non-fatal stroke events were those that
produced a neurological deﬁcit that was present for
more than 24 h. New diabetes diagnoses (including
date) were also obtained from medical record reviews.
Obtaining information on weight and height in early adult
life
Since most men in the BRHS cohort (born 1919–1939)
would have undertaken military service in early adult-
hood, either during World War II (1939–1945) or
during UK National Service (1945–1963), we sought
information on weight in early adult life from military
service records. In 2007, a questionnaire was sent to all
surviving men enquiring about military service in early
adulthood, including details of service period and
service number where available, and permission was
sought to obtain service medical records (archived at
TNT Ltd, Swadlincote, Derbyshire). We have used this
data source to obtain measurements of height and
weight, which were recorded at service entry (in both
service and medical records) and formed part of a
standard military medical classiﬁcation.19
Statistical methods
We have previously outlined the methodology used to
obtain weight at 21 years.20 In brief, when a record of
weight measurement was recorded in service records
between 20 and 22 years, this was used directly as an esti-
mate of weight at 21 years. In the absence of measured
weight between 20 and 22 years, a weight recorded
between either 17 and 19 or 23 and 25 years was used to
estimate weight at 21 years from a multilevel model
ﬁtted using all weight measurements recorded, adjusting
for age (allowing for a quadratic relationship) and
period of enlistment; including pre-World War II (1934–
1938), War (1939–1945) and post-War periods (1946–
1950, 1951–1955, 1956–1975). The model included a
random intercept allowing for clustering of measures
within individual, and a random slope for the linear
term of age allowing person-speciﬁc age slopes to be
determined. Where measured weight was not recorded,
recalled weight in 1996 was used, adjusted for recall bias
quantiﬁed by comparisons of measured and recalled
weight at 21 years (available in 694 individuals). Modest
overestimation of true weight among thinner men was
observed (mean estimated bias across the range of mea-
sured weight was 1.5 kg with a maximum of 6.9 kg esti-
mated at the lowest limit of the range of measured
weight; see online supplementary ﬁgure S1). Height
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measurements recorded in military records were used to
provide an estimate of height at 21 years using similar
methods as for weight. BMI at 21 years was calculated as
weight/height squared in kg/m2.
The exact dates of ﬁrst MI (fatal or non-fatal), ﬁrst
stroke (fatal or non-fatal) and diagnosis of diabetes were
recorded over a 30-year follow-up period from study
entry. Incidence rates for all outcomes were summarised
by quintiles of BMI-21 to examine trends. A Cox propor-
tional hazards model was used to assess the separate
effects of BMI-21 and BMI-50 on the risks of all out-
comes (adjusting for age and smoking status at baseline,
and town as a ﬁxed effect). Additionally, the effect of
BMI-50 on the risk of each outcome was stratiﬁed by
quintiles of BMI-21 to examine evidence for effect modi-
ﬁcation. Metaregression of regression coefﬁcients from
the stratiﬁed analysis were used to examine tests for
trend. The effect of BMI on each outcome was also
examined using a life course approach, by using trajec-
tories of exposure to high BMI at the two ages (BMI-21
and BMI-50). A high BMI was deﬁned when an individ-
ual was on/above the 75th centile of BMI distribution at
a speciﬁc age. This provided four mutually exclusive tra-
jectories to examine the life course patterning of disease
risk, adjusting for town (as ﬁxed effect), age and
smoking status.
RESULTS
In all, 4842 men (63% of the original cohort) had data
on height and weight at both ages (ie, BMI-21 and
BMI-50), smoking at BRHS baseline and 30 years of
follow-up data for type 2 diabetes, MI and stroke. Weight
data at 21 years of age were based on military records
for 2205 (44%) men; measured weight at age 20–
22 years was obtained directly for 1258 men and
imputed from weights between 17 and 19 years or
between 23 and 25 years of age for 947 men. Weight at
age 21 years was recalled from middle age for the
remaining 2832 men. A subset of 694 men with both
recalled and measured weight in early adult life allowed
bias in recalled weight to be quantiﬁed; modest overesti-
mation of true weight among thinner men was observed
(see online supplementary ﬁgure S1). Similar numbers
were obtained for height at 21 years of age, with 1244
men measured between 20 and 22 years of age, 963 mea-
sured between 17 and 19 or 23 and 25 years and with
2830 imputed from middle age (allowing for a very
small amount of shrinkage). Mean BMI-50 was only mar-
ginally higher among the 2890 men excluded from ana-
lysis compared with those included (25.6 vs 25.4 kg/m2,
p=0.025).
Table 1 shows the anthropometric characteristics of
the cohort at 21 and 50 years of age, overall and by quin-
tiles of BMI in early adulthood. Weight and BMI at
50 years increased with higher quintiles of BMI in early
adult life (BMI-21). Moreover, prevalences of overweight
(deﬁned as BMI ≥25 kg/m2) and obesity (deﬁned as
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BMI ≥30 kg/m2) were considerably higher at 50 years
(46%, 7.3%) compared with prevalence at 21 years
(9.6%, 1.5%). Height remained largely stable between
early adult life and middle age with a minimal amount
of shrinkage.
Table 2 summarises the incidence rates for diabetes,
MI and stroke (fatal and non-fatal) within the cohort
overall, and by quintiles of BMI-21 and BMI-50. While
there was no evidence of a trend in incidence rates for
MI or stroke (fatal and non-fatal) across quintiles of
BMI-21, incidence rates of diabetes appeared higher
among men who were in the upper quintile of BMI (the
81st–100th centile) in early life. Incidence rates for dia-
betes, MI (fatal and non-fatal) and non-fatal stroke
appeared positively associated with quintiles of BMI-50.
Table 3 shows hazard ratios (HRs) for each outcome
per unit increase in BMI (per 1 kg/m2), separately at 21
and 50 years of age. A 1 kg/m2 higher BMI-21 was asso-
ciated with a 6% higher risk for diabetes in later life
(HR 1.06, 95% CI 1.04 to 1.09), but not with a higher
MI or stroke risk. BMI-50 was strongly associated with
higher diabetes risk (HR 1.21, 95% CI 1.18 to 1.24)—
three times the effect size for BMI-21—and also with
higher risks of MI (HR 1.06, 95%CI 1.04 to 1.08) and
stroke (HR 1.04, 95% CI 1.01 to 1.07). Fatal MI and fatal
stroke showed patterns broadly similar to those for all
fatal and non-fatal MI and stroke events, respectively.
Table 4 shows the associations between life course
BMI trajectories on cardiometabolic outcomes in later
life, expressed as HRs from the reference trajectory (0–
0), that is, participants with low levels of BMI at both 21
and 50 years of age. High BMI-50 with or without high
BMI-21 was associated with approximately a threefold
higher risk of diabetes, and a 30–60% higher risk of MI
(including fatal MI). High BMI-21 with high BMI-50 was
associated with a marked increase in diabetes risk and to
a lesser extent in MI; high BMI-21 without BMI-50 was
not associated with increased risks of diabetes or cardio-
vascular disease.
The inﬂuence of BMI-21 on the associations between
BMI-50 and each outcome is summarised in table 5. The
risk of diabetes associated with high BMI-50 appeared
slightly weaker among men in the lowest quintile of
BMI-21, but there was no strong evidence of interaction
(p=0.19 for difference in effect of BMI-50 by quintile of
BMI-21—table 5). The associations between BMI-50, MI
and stroke did not differ appreciably across quintiles of
BMI-21. A sensitivity analysis performed by analysing the
ﬁrst 15 years of follow-up after BRHS baseline yield
similar results (data not presented). Moreover, associa-
tions were not materially altered by additional adjust-
ment for social class (data not presented).
DISCUSSION
Main findings
Adiposity in middle age is a well-known risk factor for
cardiovascular disease and type 2 diabetes.2 However,
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less is known about the impact of high BMI from early
adult life on these outcomes, as long-term cohort studies
(particularly from birth) rarely have follow-up to an age
when cardiometabolic outcomes readily occur. This
study provides important insight into the role of BMI, as
a measure of adiposity in early adult life on cardiovascu-
lar and diabetes risks from middle age. BMI in early
adult life was independently associated with later dia-
betes risk, but not with MI and stroke risks. BMI in
middle age was more strongly associated with type 2 dia-
betes, and was also associated with MI and stroke risks.
Relation to earlier studies
Our ﬁndings are coherent with established evidence
showing that adiposity in middle age shows strong,
graded associations, most strongly with type 2 diabetes
but also with CHD and stroke.2 4 5 11 21 The ﬁnding that
BMI in early adult life is associated with the subsequent
incidence of diabetes is consistent with recent prospect-
ive reports linking higher levels of adiposity in early
adult life to diabetes risks22–25 and with recent reports
suggesting that longer duration of adiposity (particularly
from early adult life) is related to diabetes risk.26–29 It is
also consistent with reported associations between BMI
in early adult life and insulin resistance and glycaemia,
both in the present study20 and in other cohorts.30 This
is also compatible with a recent large study of Israeli
army recruits, which showed that high BMI in adoles-
cence was strongly related to metabolic disorders in later
life.24 This study also showed that adolescents with
higher BMI who become lean in adulthood, do not have
an increase and may have a reduction in their risk of
diabetes.24 This is consistent with our ﬁnding that men
who were overweight at 21 but not at 50 had similar or
possibly lower levels of diabetes than those who were not
overweight at any time, and with experimental evidence
showing that weight loss has a marked effect on diabetes
risk.31
Earlier studies and reviews have suggested that higher
levels of adiposity in adolescence and early adult life
may be associated with risks of CHD,12 32 33 at variance
with our ﬁndings for MI and stroke here. However, the
independence of the early BMI-CHD associations has
not so far been conﬁrmed.12 32 Moreover, in the present
study, there were few participants with high levels of
body fatness in early adult life, limiting the power of the
study to detect associations between early BMI and car-
diovascular disease, which would be expected to be
weaker than those for diabetes. While BMI has been
strongly correlated with total and visceral body fat in pre-
vious studies of adults, it should be acknowledged that
BMI as a measurement of adiposity in these young men
may be more closely related to lean muscle mass than to
fat mass.34 35 It is also possible that selection bias may
have inﬂuenced the ﬁndings, particularly the possibility
that men with high BMI-21 levels developed CHD in
early middle age, making their inclusion in the study
less likely. However, the marginally higher BMI-50
among men excluded from analysis compared with
those included (approximately 0.2 kg/m2), and consist-
ency of associations between early BMI and CHD risk
between 15 and 30 years of follow-up makes this less
likely.
Strengths and limitations
This investigation is based on a geographically and
socially representative cohort study with high response
rates and exceptionally high follow-up rates. Among
men who took part in the baseline examination, it was
possible using two new sources of information, military
health records and participant recall, to obtain informa-
tion on BMI at 21 years for almost two-thirds of study
participants (65%). Information from military records
was documented methodically at the time of measure-
ment and would be expected to have a high degree of
validity. Among men with data from both sources,
recalled data were substantially consistent with military
record data, and allowed adjustment for a small bias in
recalled weight. Although the analyses were based on
two-thirds of the original cohort, and therefore being
based on a healthy survivor group, baseline BMI and car-
diovascular risk factor proﬁles in men who were or were
not included in the present analyses did not differ mark-
edly, suggesting that selection bias is unlikely to have led
to underestimation of potential associations between
BMI in early adult life and later risks of diabetes and car-
diovascular disease. This is consistent with other evi-
dence suggesting that selection bias is unlikely to have a
marked inﬂuence on exposure–outcome associations.36
However, the limited number of study participants with
Table 3 HRs for all outcomes per 1 kg/m2 higher BMI at mean ages 21 and 50 years
Outcome
BMI-21 BMI-50
N HR (95% CI) p Value N HR (95% CI) p Value
Diabetes 4842 1.06 (1.04 to 1.09) <0.001 4842 1.21 (1.18 to 1.24) <0.001
MI 4842 0.99 (0.97 to 1.02) 0.63 4842 1.06 (1.04 to 1.08) <0.001
Stroke 4842 0.99 (0.96 to 1.02) 0.48 4842 1.04 (1.01 to 1.07) 0.010
Fatal MI 4842 1.01 (0.98 to 1.04) 0.35 4842 1.07 (1.04 to 1.10) <0.001
Fatal stroke 4842 0.97 (0.92 to 1.03) 0.29 4842 1.02 (0.97 to 1.07) 0.45
HR for the effect of a 1 kg/m2 increase in BMI, adjusted for age, smoking at 50 years of age and town (fixed effect).
BMI, body mass index; MI, myocardial infarction; N, total number of participants.
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Table 4 HRs for all outcomes by patterns of high BMI at mean ages 21 and 50 years
BMI
trajectory N
BMI-21 mean
(SD)
BMI-50 mean
(SD)
Diabetes
HR (95% CI)
MI
HR (95% CI)
Stroke
HR (95% CI)
Fatal MI
HR (95% CI)
Fatal
HR (95% CI)
0–0 3055 20.6 (1.7) 23.9 (2.1) 1 1 1 1 1
1–0 637 24.9 (1.7) 25.2 (1.6) 0.81 (0.60 to 1.08) 0.95 (0.78 to 1.17) 0.81 (0.62 to 1.08) 1.05 (0.81 to 1.38) 0.65 (0.38 to 1.12)
0–1 574 21.2 (1.9) 29.3 (2.0) 3.02 (2.45 to 3.73)a 1.63 (1.37 to 1.95)a 1.25 (0.98 to 1.60) 1.80 (1.44 to 2.26)a 1.12 (0.72 to 1.74)
1–1 576 26.2 (2.9) 29.9 (2.2) 2.84 (2.32 to 3.48)a 1.28 (1.06 to 1.56)b 1.01 (0.77 to 1.32) 1.51 (1.17 to 1.94)b 0.92 (0.56 to 1.53)
For BMI-21 and BMI-50, this includes all available data.
BMI trajectories: the values 0 and 1 denote BMI below and above the 75th centile, respectively. Each couple of zeros and ones corresponds to different trajectories of high BMI in early and
middle adulthood.
HR comparing the risk of cardiovascular outcome in different trajectories of BMI with the 0–0 reference group. Estimates are adjusted for age and smoking in middle adulthood and town (fixed
effect).
ap<0.001, bp<0.05.
BMI, body mass index; MI, myocardial infarction; N, total number of participants.
Table 5 HRs for the associations between BMI at mean age 50 years and all outcomes, stratified by BMI at mean age 21 years
Diabetes MI Stroke Fatal MI Fatal stroke
N
HR
(95% CI) N HR (95% CI) N HR (95% CI) N HR (95% CI) N HR (95% CI)
Overall BMI 4842 1.21 (1.18 to 1.24)a 4842 1.06 (1.04 to 1.08)a 4842 1.04 (1.01 to 1.07)b 4842 1.07 (1.04 to 1.10)a 4842 1.02 (0.97 to 1.07)
BMI-21 quintiles
0–20% 963 1.17 (1.11 to 1.23)a 963 1.06 (1.02 to 1.11)b 963 1.04 (0.98 to 1.11) 963 1.06 (0.998 to 1.13) 963 1.07 (0.95 to 1.21)
21–40% 971 1.30 (1.20 to 1.40)a 971 1.08 (1.02 to 1.14)b 971 1.03 (0.96 to 1.11) 971 1.07 (0.99 to 1.15) 971 0.93 (0.82 to 1.06)
41–60% 971 1.24 (1.16 to 1.32)a 971 1.10 (1.04 to 1.16)a 971 1.09 (1.02 to 1.17)b 971 1.12 (1.05 to 1.21)b 971 1.04 (0.91 to 1.18)
61–80% 965 1.29 (1.21 to 1.38)a 965 1.11 (1.05 to 1.17)a 965 1.05 (0.97 to 1.14) 965 1.07 (0.99 to 1.15) 965 1.07 (0.93 to 1.23)
81–100% 972 1.27 (1.21 to 1.34)a 972 1.06 (1.01 to 1.11)b 972 1.06 (0.998 to 1.14) 972 1.09 (1.03 to 1.16)b 972 1.09 (0.97 to 1.23)
p trend 0.19 0.82 0.62 0.63 0.47
HR for the effect of a 1 kg/m2 increase in BMI in middle adulthood, adjusted for age, smoking status in middle life and town (fixed effect).
ap<0.001, bp<0.05.
BMI, body mass index; MI, myocardial infarction; N, number of participants; p trend, p value for trend across groups regarding the effect of BMI-50 (obtained from metaregression).
6
Ow
en
CG,etal.BM
J
Open
2015;5:e008105.doi:10.1136/bm
jopen-2015-008105
O
p
e
n
A
c
c
e
s
s
high levels of BMI in early life will have limited the
power of the study for detection of the effects of BMI in
early adult life on risks of MI and stroke, though they
were detectable for diabetes. A further limitation of the
study is the absence of information on weight between
age 21 years and study entry (between 40 and 59 years)
making accurate determination of duration of adiposity
between early adult life and middle age infeasible.
The analytic approaches taken in this report corres-
pond with those in other recent studies37–40 in avoiding
adjustment for adiposity levels at different ages; results
based on mutual adjustment for adiposity measures at
different stages of the life course (which are highly inter-
correlated) are likely to be misleading.32 41 42 The
approach taken has therefore focused on the compara-
tive strength and consistency of independent associa-
tions between BMI at each age time point (in early and
middle age) and cardiometabolic outcomes in later life.
Moreover, we have assessed how different patterns and
potentially cumulative/combined effects of high BMI in
early and middle age impact on cardiometabolic out-
comes. Our earlier work has demonstrated the potential
for confusion when reparameterising statistical models
examining the effect of life course BMI on disease
outcomes.20
While ﬁndings from this study are likely to be general-
isable to middle-aged and older white men, relevance to
women or a similar age (who show different patterns
and trends in body composition, eg, greater losses in
muscle mass with age), and other ethnic groups remains
to be established. BMI is only a proxy measure of adipos-
ity, and high levels of BMI may not fully capture those
that are overweight or obese, especially in historic
cohorts. Moreover, the degree to which BMI captures
true adiposity differs with age, as ageing is associated
with signiﬁcant changes in body composition.43
CONCLUSION
This study provides novel and potentially important
information on the role of BMI in early adult life on
long-term cardiovascular and diabetes risk, based on the
linkage of military service records from early adult life
to an established cohort recruited in middle age. The
results suggest that BMI in early adult life may have an
independent inﬂuence on later type 2 diabetes risk
rather than on cardiovascular disease. However, the
results of the life course analyses presented here suggest
that the increase in diabetes risk associated with high
early adult BMI may be particularly important among
men who have an elevated BMI in middle age; the
absence of an increase in diabetes risk among men who
had a high early BMI but a normal BMI in middle age
suggests that the effects of high early BMI on diabetes
may be reversible at least in part.
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